— Why it moved
Why BIVI Stock Spiked and Dumped Today — August 12, 2026
BioVie pumped on an investor webinar pitch for its Parkinson's candidate before giving up all intraday gains and cratering back toward earth.
What moved BIVI stock
BioVie Inc. is a clinical-stage biopharmaceutical company focused on neurodegenerative therapies. Management hosted a promotional webinar to discuss Phase 2 Parkinson's trial data. The presentation gave day traders an excuse to recycle headlines from the prior week.
The mechanics
A tiny 7.5 million share float collided with over 126 million shares traded during the session. That absurd turnover on a sub-$10 million market cap company guarantees violent, short-lived price swings.
BIVI by the numbers
The alert window
We alerted BIVI at $2.87 at 10:00 AM. It dipped to $2.68 shortly after—a 6.5% drawdown—before ripping up to $3.79 by 10:42 AM. That gave quick traders a 32.2% upside window over 42 minutes before the bid collapsed.
How BIVI's move ended
The rally was completely fake. BIVI tanked through the afternoon to close at $1.54, down 46.3% from our alert. With ongoing dilution risks and a classic low-float pump structure, anyone holding past late morning got crushed.
The tell: Webinar hype on recycled clinical data is an exit strategy for bagholders, not a real breakout.